PubMedopen access
Mapping the TNFR2-targeting antibody patent landscape: Insights from macro trends to structural signatures.
antibodies, monoclonal, humans, receptors, tumor necrosis factor, type ii, patents as topic, complementarity determining regions, epitopes
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 9472
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.